CSTA and ovarian carcinoma: The dataset was then queried for the presence of cystatin A. In the tampon extracts, cystatin A in samples diagnosed with ovarian cancer displayed an overall two-fold increase compared with samples diagnosed as benign when comparing the mean intensities as measured by MALDI-TOF MS (Fig. 5A).